Tema ETFs
STOK icon

Tema ETFs’s Stoke Therapeutics STOK Stock Holding History

Tema ETFs’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$564K Buy
21,696
+11,779
+119% +$356K 0.02% 396
2026
Q2 		$324K Buy
9,917
+1,377
+16% +$44.2K 0.01% 478
2026
Q1 		$278K Buy
+8,540
New +$280K 0.02% 449

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Generali Investments Management
Generali Investments Management Ljubljana, Slovenia $517M AUM 27.81% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Pension & Wealth Management Advisors
Pension & Wealth Management Advisors Waltham, Massachusetts $441M AUM 9.69% 1-Year Est. Return
Strengthening Families & Communities LLC
Strengthening Families & Communities LLC Boston, Massachusetts $459M AUM 29.64% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Tema ETFs's STOK Position: Q3 2026 in Review

Tema ETFs increased its Stoke Therapeutics (STOK) stake by 119% in Q3 2026, buying an estimated $356K and bringing the position to 21,696 shares worth $564K. The position accounts for 0.02% of the portfolio, ranked #396.

Tema ETFs first reported a position in STOK in Q1 2026 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Tema ETFs held 21,696 shares of Stoke Therapeutics worth $564K as of Q3 2026.
  • Tema ETFs bought 11,779 Stoke Therapeutics shares in Q3 2026, an estimated $356K.
  • Stoke Therapeutics made up 0.02% of Tema ETFs's portfolio in Q3 2026, its #396 holding.
  • Tema ETFs first reported a position in Stoke Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.